|
IHU Cesti aims to valorize the results generated by the researchers implicated in our program. In that purpose, we benefit of the support of the French competitivity Cluster “Atlanpole Biotherapies” pole and of valorization departments of our partners, Nantes University Hospital, French Health and Medical Research Institute (Inserm transfer) and Nantes University (SATT Ouest Valorisation) |
    |
||
| Start Up Incubation | |||
| Xenothera : The start-up project Xenothera SAS aims to bring to clinic xenogeneic cell and tissue therapies for curing diabetes mellitus type 1. |
HORAMA : a biotechnology company specialized in the development of innovative gene therapy products for the treatment of the inherited retinal diseases causing loss of Visual acuity or blindness |
||
| Patents and licences
Results generated by researchers of the IHU Cesti allowed 10 patent applications or extensions . |
|||
